These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cost-effectiveness data on biologics needed. Sheridan C; Katsnelson A Nat Biotechnol; 2005 Mar; 23(3):272-3. PubMed ID: 15765069 [No Abstract] [Full Text] [Related]
7. Where the money is. Fitzgerald M Nat Biotechnol; 2006 Mar; 24(3):240-2. PubMed ID: 16525370 [No Abstract] [Full Text] [Related]
8. Bugs or drugs, tortoises or hares? Jacobs T Nat Biotechnol; 2005 Mar; 23(3):293. PubMed ID: 15765079 [No Abstract] [Full Text] [Related]
9. Organic synthesis remains relevant in drug discovery. Mehrotra MM Nature; 2007 Oct; 449(7162):535. PubMed ID: 17914370 [No Abstract] [Full Text] [Related]
10. A change in the market--investing in diagnostics. Batchelder K; Miller P Nat Biotechnol; 2006 Aug; 24(8):922-6. PubMed ID: 16900131 [No Abstract] [Full Text] [Related]
11. Industry ponders reimbursement crisis. Bouchie A Nat Biotechnol; 2003 Apr; 21(4):347-8. PubMed ID: 12665810 [No Abstract] [Full Text] [Related]
15. Biotech patents-business as usual? Lawrence S Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861 [No Abstract] [Full Text] [Related]
16. The procedure for marketing authorization for veterinary medicinal products derived from biotechnology in the European community. Brunko P Dev Biol Stand; 1992; 79():11-5. PubMed ID: 1286745 [No Abstract] [Full Text] [Related]